
Immune Pharmaceuticals Announces Third Quarter 2015 Corporate Update, Financial Results and Conference Call Details
Expansion of Bertilimumab Phase 2 Clinical Trials to the U.S. and Europe […]
Expansion of Bertilimumab Phase 2 Clinical Trials to the U.S. and Europe […]
TSX:DRT […]
NEDERLAND, Texas, Nov. 3, 2015 /PRNewswire/ — OCI Partners LP, a Delaware limited partnership (the “Partnership”), announced its results for the three and nine months ended September 30, 2015. The Partnership owns and operates an integrated […]
PRECLINICAL DATA ON THE IL-4 RECEPTOR ANTAGONIST PRS-060 PRESENTED AT THE EUROPEAN RESPIRATORY SOCIETY CONFERENCE; MARY FITZGERALD, PH.D., TO LEAD PIERIS RESPIRATORY DRUG DEVELOPMENT PROGRAM […]
Code Rebel Corp. (NASDAQ: CDRB) […]
Tumor-targeting CD137/HER2 Bispecifics Exhibit Desired Drug-Like Properties and Tumor-Dependent T Cell Activation […]
Wall Street Analyzer’s CEO Interview Series […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com